| Plenti Group Limited (PLT) ORDINARY FULLY PAID |
Financials |
$154 |
Preliminary final report Appendix 4E
|
21 May 2025 8:23AM |
$0.835 |
$0.845 |
risen by
1.20%
|
|
PLT - Price-sensitive ASX Announcement
Full Release
Key Points
- Plenti Group Limited released its Preliminary Final Report for the year ending 31 March 2024 (Appendix 4E).
- Plenti reported a 34% increase in revenue to $192.3 million and a 53% increase in loan portfolio to $2.13 billion.
- The company achieved a statutory net profit after tax (NPAT) of $6.0 million, a significant turnaround from a loss of $5.0 million in the previous year.
- The group generated a cash NPAT of $11.0 million, up from $2.7 million last year.
- Plenti’s loan originations grew by 30% to $1.5 billion, driven by growth in automotive, renewable energy, and personal lending divisions.
- Operating expenses increased by 13% to $53.7 million, mainly due to investments in technology and people to support growth.
- Credit performance remained strong, with 90+ day arrears at 46 basis points of the loan portfolio, highlighting robust credit management.
- The company reported cash and cash equivalents of $28.3 million as at 31 March 2024, with undrawn funding commitments of approximately $900 million.
- Plenti did not declare a dividend for the reporting period.
- The report includes comprehensive financial statements, notes to accounts, and commentary on the company’s strategy, outlook, and risk factors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$79 |
Urological Expert Appointed to LTR Scientific Advisory Board
|
21 May 2025 8:22AM |
$0.390 |
$0.435 |
risen by
11.54%
|
|
LTP - Price-sensitive ASX Announcement
Full Release
Key Points
- LTR Pharma Ltd has appointed Professor Christopher Chapple to its Scientific Advisory Board.
- Professor Chapple is recognized as a leading expert in the field of urology.
- The appointment is intended to support the late-stage development of SPONTAN, LTR Pharma’s proprietary nasal spray formulation of sildenafil.
- SPONTAN aims to offer a fast-acting alternative for the treatment of erectile dysfunction.
- Professor Chapple’s role includes providing guidance on clinical programs, regulatory affairs, and strengthening ties with the urological community.
- The announcement underscores LTR Pharma’s commitment to advancing innovative treatments in men’s health.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$65 |
Update - Notification of buy-back - M7T
|
21 May 2025 8:22AM |
$0.375 |
$0.275 |
fallen by
26.67%
|
|
| Skylark Minerals Limited (SKM) ORDINARY FULLY PAID |
Materials |
$37 |
Field Team Mobilised to Simon Project, Mt Isa
|
21 May 2025 8:22AM |
$0.180 |
$0.280 |
risen by
55.56%
|
|
SKM - Price-sensitive ASX Announcement
Full Release
Key Points
- Skylark Minerals Limited (ASX: SKM) has mobilised its field team to the Simon Project near Mt Isa, Queensland.
- The Simon Project targets copper and critical minerals exploration.
- Initial fieldwork will include geological mapping, rock chip sampling, and planning for geophysical surveys.
- The project area is in proximity to established mining operations and infrastructure.
- SKM aims to identify and advance large-scale base metal deposits.
- The exploration program is designed to improve geological understanding and support future resource definition.
- This initiative marks a significant step forward in SKM’s exploration strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dalrymple Bay Infrastructure Limited (DBI) FULLY PAID ORDINARY/NOTES STAPLED SECURITIES |
Industrials |
$2,593 |
2025 Annual General Meeting
|
21 May 2025 8:22AM |
$4.090 |
$5.230 |
risen by
27.87%
|
|
| AVADA Group Limited (AVD) ORDINARY FULLY PAID |
Industrials |
$8 |
Final Director's Interest Notice JW LB
|
21 May 2025 8:22AM |
$0.245 |
$0.090 |
fallen by
63.27%
|
|
| Noxopharm Limited (NOX) ORDINARY FULLY PAID |
Health Care |
$22 |
NYR: Notice of Ceasing to be a Substantial Holder - NOX
|
21 May 2025 8:21AM |
$0.068 |
$0.070 |
risen by
2.94%
|
|
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$137 |
Notice of Ceasing to be a Substantial Holder - NOX
|
21 May 2025 8:21AM |
$0.110 |
$0.560 |
risen by
409.09%
|
|
| Clearview Wealth Limited (CVW) ORDINARY FULLY PAID |
Financials |
$396 |
Update - Notification of buy-back - CVW
|
21 May 2025 8:21AM |
$0.485 |
$0.630 |
risen by
29.90%
|
|
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$169 |
Ceasing to be a substantial holder
|
21 May 2025 8:21AM |
$0.021 |
$0.047 |
risen by
123.81%
|
|
| Top End Energy Limited (TEE) ORDINARY FULLY PAID |
Energy |
$10 |
Proposed issue of securities - TEE
|
21 May 2025 8:21AM |
$0.066 |
$0.037 |
fallen by
43.94%
|
|
| Cogstate Limited (CGS) ORDINARY FULLY PAID |
Health Care |
$405 |
Notification of cessation of securities - CGS
|
21 May 2025 8:21AM |
$1.340 |
$2.370 |
risen by
76.87%
|
|
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$867 |
Appointment of Director and Succession of Chair
|
21 May 2025 8:21AM |
$7.950 |
$6.480 |
fallen by
18.49%
|
|
| Cogstate Limited (CGS) ORDINARY FULLY PAID |
Health Care |
$405 |
Retirement of Non-Executive Director
|
21 May 2025 8:21AM |
$1.340 |
$2.370 |
risen by
76.87%
|
|
| Advance Metals Limited (AVM) ORDINARY FULLY PAID |
Materials |
$47 |
First Diamond Hole Completed at Yoquivo, Mexico
|
21 May 2025 8:21AM |
$0.042 |
$0.099 |
risen by
135.71%
|
|
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$1,715 |
Update - Notification of buy-back - ORA
|
21 May 2025 8:21AM |
$1.955 |
$1.400 |
fallen by
28.39%
|
|
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,653 |
Notification of cessation of securities - MFG
|
21 May 2025 8:20AM |
$8.500 |
$8.900 |
risen by
4.71%
|
|
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,653 |
Update - Notification of buy-back - MFG
|
21 May 2025 8:20AM |
$8.500 |
$8.900 |
risen by
4.71%
|
|
| Future Generation Global Limited (FGG) ORDINARY FULLY PAID |
Financials |
$692 |
Board of Directors update
|
21 May 2025 8:20AM |
$1.425 |
$1.725 |
risen by
21.05%
|
|
| Lanthanein Resources Ltd (LNR) ORDINARY FULLY PAID |
Materials |
- |
Director Appointment
|
21 May 2025 8:20AM |
$0.001 |
$0.067 |
risen by
6,600%
|
|
| Webjet Group Limited (WJL) ORDINARY FULLY PAID |
Consumer Discretionary |
$208 |
Sustainability Report
|
21 May 2025 8:20AM |
$0.870 |
$0.530 |
fallen by
39.08%
|
|
| Webjet Group Limited (WJL) ORDINARY FULLY PAID |
Consumer Discretionary |
$208 |
Appendix 4G and Corporate Governance Statement
|
21 May 2025 8:20AM |
$0.870 |
$0.530 |
fallen by
39.08%
|
|
| Rox Resources Limited (RXL) ORDINARY FULLY PAID |
Materials |
$605 |
High gold recovery confirmed at Youanmi
|
21 May 2025 8:20AM |
$0.275 |
$0.435 |
risen by
58.18%
|
|
| Webjet Group Limited (WJL) ORDINARY FULLY PAID |
Consumer Discretionary |
$208 |
FY25 Investor Presentation
|
21 May 2025 8:20AM |
$0.870 |
$0.530 |
fallen by
39.08%
|
|
WJL - Price-sensitive ASX Announcement
Full Release
Key Points
- Webjet Group Limited is demonstrating continued strong recovery and growth post-pandemic.
- The company operates across both B2B (WebBeds) and B2C (Webjet OTA, GoSee) travel segments.
- WebBeds is positioned as the #2 global B2B provider, with ongoing geographic expansion and technology-driven scalability.
- Webjet OTA remains a leading player in the Australian and New Zealand travel markets.
- GoSee is focused on vehicle rental bookings and is being repositioned for improved profitability.
- Key financial highlights include record TTV (Total Transaction Value), revenue, and EBITDA levels.
- Disciplined cost control and a strong balance sheet underpin the company’s growth strategy.
- Strategic priorities for FY25 include investing in technology, expanding global reach, and pursuing new revenue opportunities.
- Webjet is investing in digital transformation to enhance customer experience and operational efficiency.
- The company remains committed to sustainable growth and maximizing shareholder returns.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Webjet Group Limited (WJL) ORDINARY FULLY PAID |
Consumer Discretionary |
$208 |
FY25 Results Announcement
|
21 May 2025 8:20AM |
$0.870 |
$0.530 |
fallen by
39.08%
|
|
WJL - Price-sensitive ASX Announcement
Full Release
Key Points
- Webjet Group Limited released its FY25 Results Announcement, detailing overall company performance.
- The company operates through key segments: WebBeds, Webjet OTA, and GoSee, each contributing to group results.
- Financial highlights include revenue growth, strong EBITDA performance, and effective cost management.
- Strategic investments in technology and expansion initiatives are driving operational efficiencies.
- The company continues to focus on digital transformation, customer service excellence, and strengthening its market position.
- Management commentary addresses industry challenges, competitive landscape, and the group’s resilience.
- Forward-looking statements and FY25 guidance provide insights into the company’s outlook and strategic priorities.
- The announcement covers operational updates, financial statements, and segment analysis up to page 60 of the document.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.